Your browser doesn't support javascript.
loading
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study.
Vannucchi, Alessandro M; Sordi, Benedetta; Morettini, Alessandro; Nozzoli, Carlo; Poggesi, Loredana; Pieralli, Filippo; Bartoloni, Alessandro; Atanasio, Alessandro; Miselli, Filippo; Paoli, Chiara; Loscocco, Giuseppe G; Fanelli, Andrea; Para, Ombretta; Berni, Andrea; Tassinari, Irene; Zammarchi, Lorenzo; Maggi, Laura; Mazzoni, Alessio; Scotti, Valentina; Falchetti, Giorgia; Malandrino, Danilo; Luise, Fabio; Millotti, Giovanni; Bencini, Sara; Capone, Manuela; Piccinni, Marie Pierre; Annunziato, Francesco; Guglielmelli, Paola.
Afiliação
  • Vannucchi AM; Center Research Innovation of Myeloproliferative Neoplasms (CRIMM), SOD Hematology, University of Florence and AOU Careggi, Florence, Italy. amvannucchi@unifi.it.
  • Sordi B; Center Research Innovation of Myeloproliferative Neoplasms (CRIMM), SOD Hematology, University of Florence and AOU Careggi, Florence, Italy.
  • Morettini A; Internal Medicine Unit 2, AOU Careggi, Florence, Italy.
  • Nozzoli C; Internal Medicine Unit 1, AOU Careggi, Florence, Italy.
  • Poggesi L; Internal Medicine Unit 3, AOU Careggi, Florence, Italy.
  • Pieralli F; Intermediate Care Unit COVID-19, AOU Careggi, Florence, Italy.
  • Bartoloni A; Infectious and Tropical Diseases Unit, AOU Careggi, Florence, Italy.
  • Atanasio A; Center Research Innovation of Myeloproliferative Neoplasms (CRIMM), SOD Hematology, University of Florence and AOU Careggi, Florence, Italy.
  • Miselli F; Center Research Innovation of Myeloproliferative Neoplasms (CRIMM), SOD Hematology, University of Florence and AOU Careggi, Florence, Italy.
  • Paoli C; Center Research Innovation of Myeloproliferative Neoplasms (CRIMM), SOD Hematology, University of Florence and AOU Careggi, Florence, Italy.
  • Loscocco GG; Center Research Innovation of Myeloproliferative Neoplasms (CRIMM), SOD Hematology, University of Florence and AOU Careggi, Florence, Italy.
  • Fanelli A; Internal Medicine Unit 2, AOU Careggi, Florence, Italy.
  • Para O; Internal Medicine Unit 1, AOU Careggi, Florence, Italy.
  • Berni A; Internal Medicine Unit 3, AOU Careggi, Florence, Italy.
  • Tassinari I; Intermediate Care Unit COVID-19, AOU Careggi, Florence, Italy.
  • Zammarchi L; Infectious and Tropical Diseases Unit, AOU Careggi, Florence, Italy.
  • Maggi L; Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy.
  • Mazzoni A; Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy.
  • Scotti V; Internal Medicine Unit 2, AOU Careggi, Florence, Italy.
  • Falchetti G; Internal Medicine Unit 2, AOU Careggi, Florence, Italy.
  • Malandrino D; Internal Medicine Unit 3, AOU Careggi, Florence, Italy.
  • Luise F; Intermediate Care Unit COVID-19, AOU Careggi, Florence, Italy.
  • Millotti G; Infectious and Tropical Diseases Unit, AOU Careggi, Florence, Italy.
  • Bencini S; Cytometry and Immunotherapy Diagnostic Center (CDCI), AOU Careggi, Florence, Italy.
  • Capone M; Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy.
  • Piccinni MP; Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy.
  • Annunziato F; Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy.
  • Guglielmelli P; Cytometry and Immunotherapy Diagnostic Center (CDCI), AOU Careggi, Florence, Italy.
Leukemia ; 35(4): 1121-1133, 2021 04.
Article em En | MEDLINE | ID: mdl-32814839
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Janus Quinase 1 / Janus Quinase 2 / Ensaios de Uso Compassivo / Inibidores de Janus Quinases / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Janus Quinase 1 / Janus Quinase 2 / Ensaios de Uso Compassivo / Inibidores de Janus Quinases / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article